US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 3.040
  • +0.090+3.05%
Close May 9 16:00 ET
224.44MMarket Cap-37073P/E (TTM)

About Conduit Pharmaceuticals Company

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.

Company Profile

SymbolCDT
Company NameConduit Pharmaceuticals
Listing DateMar 28, 2022
CEOMr. David Tapolczay
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4995 Murphy Canyon Road,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92123
Phone1-760-471-8536
Websitehttp://www.conduitpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • David Tapolczay
  • Chief Executive Officer and Director
  • 1.34M
  • Adam Sragovicz
  • Chief Financial Officer and Principal Accounting Officer
  • 527.41K
  • Dr. Freda C. Lewis-Hall,M.D.
  • Chairman of the Board
  • 275.31K
  • James Bligh
  • Director
  • 1.44M
  • Andrew James Regan
  • Director
  • 842.08K
  • Jennifer I. McNealey
  • Independent Director
  • 267.06K
  • Faith L. Charles
  • Independent Director
  • 267.43K
  • Chele Chiavacci Farley
  • Independent Director
  • 268.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg